Report Detail

Other Global In-Silico Drug Discovery Supply, Demand and Key Producers, 2026-2032

  • RnM4667828
  • |
  • 22 January, 2026
  • |
  • Global
  • |
  • 105 Pages
  • |
  • GIR
  • |
  • Other

The global In-Silico Drug Discovery market size is expected to reach $ 6071 million by 2032, rising at a market growth of 11.6% CAGR during the forecast period (2026-2032).
In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
This report studies the global In-Silico Drug Discovery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for In-Silico Drug Discovery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of In-Silico Drug Discovery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global In-Silico Drug Discovery total market, 2021-2032, (USD Million)
Global In-Silico Drug Discovery total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: In-Silico Drug Discovery total market, key domestic companies, and share, (USD Million)
Global In-Silico Drug Discovery revenue by player, revenue and market share 2021-2026, (USD Million)
Global In-Silico Drug Discovery total market by Type, CAGR, 2021-2032, (USD Million)
Global In-Silico Drug Discovery total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global In-Silico Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schrödinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world In-Silico Drug Discovery market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global In-Silico Drug Discovery Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global In-Silico Drug Discovery Market, Segmentation by Type:
Software as a Service (Cloud)
Consultancy as a Service
Software
Global In-Silico Drug Discovery Market, Segmentation by Application:
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
Companies Profiled:
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Key Questions Answered
1. How big is the global In-Silico Drug Discovery market?
2. What is the demand of the global In-Silico Drug Discovery market?
3. What is the year over year growth of the global In-Silico Drug Discovery market?
4. What is the total value of the global In-Silico Drug Discovery market?
5. Who are the Major Players in the global In-Silico Drug Discovery market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 In-Silico Drug Discovery Introduction
  • 1.2 World In-Silico Drug Discovery Market Size & Forecast (2021 & 2025 & 2032)
  • 1.3 World In-Silico Drug Discovery Total Market by Region (by Headquarter Location)
    • 1.3.1 World In-Silico Drug Discovery Market Size by Region (2021-2032), (by Headquarter Location)
    • 1.3.2 United States Based Company In-Silico Drug Discovery Revenue (2021-2032)
    • 1.3.3 China Based Company In-Silico Drug Discovery Revenue (2021-2032)
    • 1.3.4 Europe Based Company In-Silico Drug Discovery Revenue (2021-2032)
    • 1.3.5 Japan Based Company In-Silico Drug Discovery Revenue (2021-2032)
    • 1.3.6 South Korea Based Company In-Silico Drug Discovery Revenue (2021-2032)
    • 1.3.7 ASEAN Based Company In-Silico Drug Discovery Revenue (2021-2032)
    • 1.3.8 India Based Company In-Silico Drug Discovery Revenue (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 In-Silico Drug Discovery Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Major Market Trends

2 Demand Summary

  • 2.1 World In-Silico Drug Discovery Consumption Value (2021-2032)
  • 2.2 World In-Silico Drug Discovery Consumption Value by Region
    • 2.2.1 World In-Silico Drug Discovery Consumption Value by Region (2021-2026)
    • 2.2.2 World In-Silico Drug Discovery Consumption Value Forecast by Region (2027-2032)
  • 2.3 United States In-Silico Drug Discovery Consumption Value (2021-2032)
  • 2.4 China In-Silico Drug Discovery Consumption Value (2021-2032)
  • 2.5 Europe In-Silico Drug Discovery Consumption Value (2021-2032)
  • 2.6 Japan In-Silico Drug Discovery Consumption Value (2021-2032)
  • 2.7 South Korea In-Silico Drug Discovery Consumption Value (2021-2032)
  • 2.8 ASEAN In-Silico Drug Discovery Consumption Value (2021-2032)
  • 2.9 India In-Silico Drug Discovery Consumption Value (2021-2032)

3 World In-Silico Drug Discovery Companies Competitive Analysis

  • 3.1 World In-Silico Drug Discovery Revenue by Player (2021-2026)
  • 3.2 Industry Rank and Concentration Rate (CR)
    • 3.2.1 Global In-Silico Drug Discovery Industry Rank of Major Players
    • 3.2.2 Global Concentration Ratios (CR4) for In-Silico Drug Discovery in 2025
    • 3.2.3 Global Concentration Ratios (CR8) for In-Silico Drug Discovery in 2025
  • 3.3 In-Silico Drug Discovery Company Evaluation Quadrant
  • 3.4 In-Silico Drug Discovery Market: Overall Company Footprint Analysis
    • 3.4.1 In-Silico Drug Discovery Market: Region Footprint
    • 3.4.2 In-Silico Drug Discovery Market: Company Product Type Footprint
    • 3.4.3 In-Silico Drug Discovery Market: Company Product Application Footprint
  • 3.5 Competitive Environment
    • 3.5.1 Historical Structure of the Industry
    • 3.5.2 Barriers of Market Entry
    • 3.5.3 Factors of Competition
  • 3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)

  • 4.1 United States VS China: In-Silico Drug Discovery Revenue Comparison (by Headquarter Location)
    • 4.1.1 United States VS China: In-Silico Drug Discovery Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
    • 4.1.2 United States VS China: In-Silico Drug Discovery Revenue Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States Based Companies VS China Based Companies: In-Silico Drug Discovery Consumption Value Comparison
    • 4.2.1 United States VS China: In-Silico Drug Discovery Consumption Value Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: In-Silico Drug Discovery Consumption Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States Based In-Silico Drug Discovery Companies and Market Share, 2021-2026
    • 4.3.1 United States Based In-Silico Drug Discovery Companies, Headquarters (States, Country)
    • 4.3.2 United States Based Companies In-Silico Drug Discovery Revenue, (2021-2026)
  • 4.4 China Based Companies In-Silico Drug Discovery Revenue and Market Share, 2021-2026
    • 4.4.1 China Based In-Silico Drug Discovery Companies, Company Headquarters (Province, Country)
    • 4.4.2 China Based Companies In-Silico Drug Discovery Revenue, (2021-2026)
  • 4.5 Rest of World Based In-Silico Drug Discovery Companies and Market Share, 2021-2026
    • 4.5.1 Rest of World Based In-Silico Drug Discovery Companies, Headquarters (Province, Country)
    • 4.5.2 Rest of World Based Companies In-Silico Drug Discovery Revenue (2021-2026)

5 Market Analysis by Type

  • 5.1 World In-Silico Drug Discovery Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Software as a Service (Cloud)
    • 5.2.2 Consultancy as a Service
    • 5.2.3 Software
  • 5.3 Market Segment by Type
    • 5.3.1 World In-Silico Drug Discovery Market Size by Type (2021-2026)
    • 5.3.2 World In-Silico Drug Discovery Market Size by Type (2027-2032)
    • 5.3.3 World In-Silico Drug Discovery Market Size Market Share by Type (2027-2032)

6 Market Analysis by Application

  • 6.1 World In-Silico Drug Discovery Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Contract Research Organization
    • 6.2.2 Pharmaceutical Industry
    • 6.2.3 Academic and Research Institutes
    • 6.2.4 Others
  • 6.3 Market Segment by Application
    • 6.3.1 World In-Silico Drug Discovery Market Size by Application (2021-2026)
    • 6.3.2 World In-Silico Drug Discovery Market Size by Application (2027-2032)
    • 6.3.3 World In-Silico Drug Discovery Market Size Market Share by Application (2021-2032)

7 Company Profiles

  • 7.1 Charles River
    • 7.1.1 Charles River Details
    • 7.1.2 Charles River Major Business
    • 7.1.3 Charles River In-Silico Drug Discovery Product and Services
    • 7.1.4 Charles River In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Charles River Recent Developments/Updates
    • 7.1.6 Charles River Competitive Strengths & Weaknesses
  • 7.2 Certara USA, Inc.
    • 7.2.1 Certara USA, Inc. Details
    • 7.2.2 Certara USA, Inc. Major Business
    • 7.2.3 Certara USA, Inc. In-Silico Drug Discovery Product and Services
    • 7.2.4 Certara USA, Inc. In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Certara USA, Inc. Recent Developments/Updates
    • 7.2.6 Certara USA, Inc. Competitive Strengths & Weaknesses
  • 7.3 Evotec
    • 7.3.1 Evotec Details
    • 7.3.2 Evotec Major Business
    • 7.3.3 Evotec In-Silico Drug Discovery Product and Services
    • 7.3.4 Evotec In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Evotec Recent Developments/Updates
    • 7.3.6 Evotec Competitive Strengths & Weaknesses
  • 7.4 Dassault System (Biovia)
    • 7.4.1 Dassault System (Biovia) Details
    • 7.4.2 Dassault System (Biovia) Major Business
    • 7.4.3 Dassault System (Biovia) In-Silico Drug Discovery Product and Services
    • 7.4.4 Dassault System (Biovia) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Dassault System (Biovia) Recent Developments/Updates
    • 7.4.6 Dassault System (Biovia) Competitive Strengths & Weaknesses
  • 7.5 Albany Molecular Research Inc. (AMRI)
    • 7.5.1 Albany Molecular Research Inc. (AMRI) Details
    • 7.5.2 Albany Molecular Research Inc. (AMRI) Major Business
    • 7.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product and Services
    • 7.5.4 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Albany Molecular Research Inc. (AMRI) Recent Developments/Updates
    • 7.5.6 Albany Molecular Research Inc. (AMRI) Competitive Strengths & Weaknesses
  • 7.6 Selvita
    • 7.6.1 Selvita Details
    • 7.6.2 Selvita Major Business
    • 7.6.3 Selvita In-Silico Drug Discovery Product and Services
    • 7.6.4 Selvita In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Selvita Recent Developments/Updates
    • 7.6.6 Selvita Competitive Strengths & Weaknesses
  • 7.7 Schrödinger, Inc.
    • 7.7.1 Schrödinger, Inc. Details
    • 7.7.2 Schrödinger, Inc. Major Business
    • 7.7.3 Schrödinger, Inc. In-Silico Drug Discovery Product and Services
    • 7.7.4 Schrödinger, Inc. In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Schrödinger, Inc. Recent Developments/Updates
    • 7.7.6 Schrödinger, Inc. Competitive Strengths & Weaknesses
  • 7.8 GVK BIO
    • 7.8.1 GVK BIO Details
    • 7.8.2 GVK BIO Major Business
    • 7.8.3 GVK BIO In-Silico Drug Discovery Product and Services
    • 7.8.4 GVK BIO In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.8.5 GVK BIO Recent Developments/Updates
    • 7.8.6 GVK BIO Competitive Strengths & Weaknesses
  • 7.9 OpenEye Scientific Software
    • 7.9.1 OpenEye Scientific Software Details
    • 7.9.2 OpenEye Scientific Software Major Business
    • 7.9.3 OpenEye Scientific Software In-Silico Drug Discovery Product and Services
    • 7.9.4 OpenEye Scientific Software In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.9.5 OpenEye Scientific Software Recent Developments/Updates
    • 7.9.6 OpenEye Scientific Software Competitive Strengths & Weaknesses
  • 7.10 Chemical Computing Group (CCG)
    • 7.10.1 Chemical Computing Group (CCG) Details
    • 7.10.2 Chemical Computing Group (CCG) Major Business
    • 7.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Product and Services
    • 7.10.4 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Chemical Computing Group (CCG) Recent Developments/Updates
    • 7.10.6 Chemical Computing Group (CCG) Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 In-Silico Drug Discovery Industry Chain
  • 8.2 In-Silico Drug Discovery Upstream Analysis
  • 8.3 In-Silico Drug Discovery Midstream Analysis
  • 8.4 In-Silico Drug Discovery Downstream Analysis

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on In-Silico Drug Discovery. Industry analysis & Market Report on In-Silico Drug Discovery is a syndicated market report, published as Global In-Silico Drug Discovery Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of In-Silico Drug Discovery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,480.00
    $6,720.00
    $8,960.00
    3,463.04
    5,194.56
    6,926.08
    4,170.88
    6,256.32
    8,341.76
    684,051.20
    1,026,076.80
    1,368,102.40
    378,112.00
    567,168.00
    756,224.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report